- Home
- KYMR vs AIR Comparison
KYMR vs AIR Comparison
Compare KYMR & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- AIR
- Stock Information
- Founded
- KYMR 2015
- AIR 1951
- Country
- KYMR United States
- AIR United States
- Employees
- KYMR N/A
- AIR N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- AIR Aerospace
- Sector
- KYMR Health Care
- AIR Industrials
- Exchange
- KYMR Nasdaq
- AIR Nasdaq
- Market Cap
- KYMR 2.1B
- AIR 2.3B
- IPO Year
- KYMR 2020
- AIR 1988
- Fundamental
- Price
- KYMR $33.45
- AIR $66.16
- Analyst Decision
- KYMR Buy
- AIR Strong Buy
- Analyst Count
- KYMR 13
- AIR 4
- Target Price
- KYMR $56.69
- AIR $81.50
- AVG Volume (30 Days)
- KYMR 695.8K
- AIR 201.4K
- Earning Date
- KYMR 05-01-2025
- AIR 03-24-2025
- Dividend Yield
- KYMR N/A
- AIR N/A
- EPS Growth
- KYMR N/A
- AIR N/A
- EPS
- KYMR N/A
- AIR 0.28
- Revenue
- KYMR $47,072,000.00
- AIR $2,571,600,000.00
- Revenue This Year
- KYMR $44.93
- AIR $20.23
- Revenue Next Year
- KYMR N/A
- AIR $6.46
- P/E Ratio
- KYMR N/A
- AIR $233.00
- Revenue Growth
- KYMR N/A
- AIR 18.53
- 52 Week Low
- KYMR $29.07
- AIR $54.71
- 52 Week High
- KYMR $53.27
- AIR $76.34
- Technical
- Relative Strength Index (RSI)
- KYMR 44.68
- AIR 54.81
- Support Level
- KYMR $31.54
- AIR $61.18
- Resistance Level
- KYMR $31.66
- AIR $65.83
- Average True Range (ATR)
- KYMR 2.31
- AIR 1.93
- MACD
- KYMR 0.37
- AIR 0.36
- Stochastic Oscillator
- KYMR 51.20
- AIR 86.91
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About AIR AAR Corp.
AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.